Susanne Wilde

1.9k total citations
20 papers, 542 citations indexed

About

Susanne Wilde is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Susanne Wilde has authored 20 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Susanne Wilde's work include Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (13 papers) and Immune Cell Function and Interaction (10 papers). Susanne Wilde is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (13 papers) and Immune Cell Function and Interaction (10 papers). Susanne Wilde collaborates with scholars based in Germany, United States and United Kingdom. Susanne Wilde's co-authors include Dolores J. Schendel, Bernhard Frankenberger, Stefani Spranger, Wolfgang Uckert, Matthias Leisegang, Barbara Mosetter, Slavoljub Milosevic, Daniel Sommermeyer, Maja Bürdek and Heike Pohla and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Susanne Wilde

20 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Wilde Germany 13 430 345 142 100 28 20 542
Y. Maurice Morillon United States 11 386 0.9× 294 0.9× 85 0.6× 77 0.8× 15 0.5× 19 527
Annelies W. Turksma Netherlands 12 278 0.6× 240 0.7× 92 0.6× 42 0.4× 24 0.9× 20 443
Korina G. Veenstra United States 6 317 0.7× 216 0.6× 139 1.0× 54 0.5× 25 0.9× 8 484
Stephanie Silveria United States 5 472 1.1× 328 1.0× 223 1.6× 84 0.8× 32 1.1× 6 723
Hilde Omholt Norway 6 579 1.3× 384 1.1× 131 0.9× 37 0.4× 52 1.9× 7 689
Thierry Connerotte Belgium 11 533 1.2× 291 0.8× 224 1.6× 37 0.4× 32 1.1× 14 629
Lois Hageman Netherlands 10 289 0.7× 315 0.9× 69 0.5× 49 0.5× 29 1.0× 14 419
Samuel Alsén Sweden 9 513 1.2× 277 0.8× 191 1.3× 56 0.6× 20 0.7× 15 737
Kari Lislerud Norway 7 398 0.9× 359 1.0× 237 1.7× 86 0.9× 9 0.3× 9 610
Kathryn Ruisaard United States 9 272 0.6× 324 0.9× 160 1.1× 129 1.3× 77 2.8× 16 507

Countries citing papers authored by Susanne Wilde

Since Specialization
Citations

This map shows the geographic impact of Susanne Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Wilde more than expected).

Fields of papers citing papers by Susanne Wilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Wilde. The network helps show where Susanne Wilde may publish in the future.

Co-authorship network of co-authors of Susanne Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Wilde. A scholar is included among the top collaborators of Susanne Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Wilde. Susanne Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Schlenker, Ramona, Matthias Leisegang, Svenja Rühland, et al.. (2017). Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy. Cancer Research. 77(13). 3577–3590. 33 indexed citations
4.
Kieback, Elisa, et al.. (2017). Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide–MHC Complexes for T-Cell Receptor Immunotherapy. Human Gene Therapy. 28(12). 1158–1168. 14 indexed citations
5.
Wilde, Susanne, Katrin Voigt, Elisa Kieback, et al.. (2015). Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8+ T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7. PLoS ONE. 10(3). e0121633–e0121633. 9 indexed citations
6.
Pinto, Sheena, Daniel Sommermeyer, Susanne Wilde, et al.. (2014). Misinitiation of intrathymic MART‐1 transcription and biased TCR usage explain the high frequency of MART‐1‐specific T cells. European Journal of Immunology. 44(9). 2811–2821. 31 indexed citations
7.
Wilde, Susanne, et al.. (2013). Induction and isolation of tumor antigen-specific CD4+ T lymphocytes using sorting signal directed MHC class-II expression. Journal for ImmunoTherapy of Cancer. 1(S1). 1 indexed citations
8.
Raffegerst, Silke, et al.. (2013). Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo. Journal for ImmunoTherapy of Cancer. 1(S1). 1 indexed citations
9.
Wilde, Susanne & Dolores J. Schendel. (2012). High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them. OncoImmunology. 1(9). 1643–1644. 8 indexed citations
10.
Wilde, Susanne, et al.. (2012). Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells. OncoImmunology. 1(2). 129–140. 9 indexed citations
11.
Spranger, Stefani, Irmela Jeremias, Susanne Wilde, et al.. (2012). TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo. Blood. 119(15). 3440–3449. 49 indexed citations
12.
Wilde, Susanne, Daniel Sommermeyer, Matthias Leisegang, et al.. (2012). Human Antitumor CD8+ T Cells Producing Th1 Polycytokines Show Superior Antigen Sensitivity and Tumor Recognition. The Journal of Immunology. 189(2). 598–605. 31 indexed citations
13.
Leisegang, Matthias, Susanne Wilde, Stefani Spranger, et al.. (2010). MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors. Journal of Clinical Investigation. 120(11). 3869–3877. 72 indexed citations
14.
Bürdek, Maja, et al.. (2010). Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation. Journal of Translational Medicine. 8(1). 90–90. 39 indexed citations
15.
Braun, Monika, Silke Raffegerst, Susanne Wilde, et al.. (2010). The CD6 Scavenger Receptor Is Differentially Expressed on a CD56<sup>dim</sup> Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion. Journal of Innate Immunity. 3(4). 420–434. 44 indexed citations
16.
Spranger, Stefani, Maja Bürdek, Susanne Wilde, et al.. (2010). Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075. The Journal of Immunology. 185(1). 738–747. 63 indexed citations
17.
Wilde, Susanne, Daniel Sommermeyer, Bernhard Frankenberger, et al.. (2009). Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity. Blood. 114(10). 2131–2139. 71 indexed citations
18.
Wilde, Susanne, Anke Zobywalski, Elfriede Noeßner, et al.. (2008). Inhibitory Effect of RNA Pool Complexity on Stimulatory Capacity of RNA-pulsed Dendritic Cells. Journal of Immunotherapy. 31(1). 52–62. 13 indexed citations
19.
Frankenberger, Bernhard, Elfriede Noeßner, Christine S. Falk, et al.. (2005). Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells. World Journal of Urology. 23(3). 166–174. 26 indexed citations
20.
Drexler, G., Susanne Wilde, Wolfgang Beisker, et al.. (2004). The rate of extrachromosomal homologous recombination within a novel reporter plasmid is elevated in cells lacking functional ATM protein. DNA repair. 3(10). 1345–1353. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Maurice Morillon Breakdown of academic impact, for papers by Annelies W. Turksma Breakdown of academic impact, for papers by Korina G. Veenstra Breakdown of academic impact, for papers by Stephanie Silveria Breakdown of academic impact, for papers by Hilde Omholt Breakdown of academic impact, for papers by Thierry Connerotte Breakdown of academic impact, for papers by Lois Hageman Breakdown of academic impact, for papers by Samuel Alsén Breakdown of academic impact, for papers by Kari Lislerud Breakdown of academic impact, for papers by Kathryn Ruisaard
Rankless by CCL
2026